Epistem Betting BD Distribution Deal for POC TB Test Will Spur Interest in Genedrive Platform

UK-based molecular diagnostics developer Epistem said this week that Becton Dickinson will distribute Epistem's point-of-care assay for Mycobacterium tuberculosis and rifampin resistance on a global basis excluding India and the Indian sub-continent.

Powered by WPeMatico